نتایج جستجو برای: hcv genotype

تعداد نتایج: 109082  

Journal: :Gut 1995
G H Haydon L M Jarvis P Simmonds D J Harrison O J Garden P C Hayes

BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. The geographical prevalence varies considerably in different countries and Scotland is regarded as an area of low risk for the disease. AIMS To assess the association between chronic hepatitis C infection (HCV) and HCC in a population of patients presenting to a single hospital. PATIENTS One hundred an...

Journal: :Journal of Korean Medical Science 2002
Young Sik Kim Yoon-Ok Ahn Hyo Suk Lee

To investigate risk factors for HCV infection according to the genotype, we studied 178 patients positive for HCV-PCR and 226 controls that were negative for the anti-HCV antibody. One hundred and twenty five controls (community control) were recruited from spouses of HCV-PCR-positive patients and the other 101 from hospital visitors (hospital control). HCV genotyping was performed by PCR, and ...

2016
Seyed Moayed Alavian Behzad Hajarizadeh Kamran Bagheri Lankarani Heidar Sharafi Nasser Ebrahimi Daryani Shahin Merat Minoo Mohraz Masoud Mardani Mohamad Reza Fattahi Hossein Poustchi Mehri Nikbin Mahmood Nabavi Peyman Adibi Masood Ziaee Bita Behnava Mohammad Saeid Rezaee-Zavareh Massimo Colombo Hatef Massoumi Abdul Rahman Bizri Bijan Eghtesad Majid Amiri Ali Namvar Khashayar Hesamizadeh Reza Malekzadeh

CONTEXT Hepatitis C virus (HCV) infection is a major public health issue worldwide, including Iran. The new direct-acting antiviral agents (DAAs) with high efficacy have changed the landscape of HCV treatment. This guideline provides updated recommendations for clinical management of HCV infection in Iran. EVIDENCE ACQUISITION The recommendations of this guideline are based on international a...

Journal: :Gastroenterology 2016
Edward J Gane Christian Schwabe Robert H Hyland Yin Yang Evguenia Svarovskaia Luisa M Stamm Diana M Brainard John G McHutchison Catherine A Stedman

BACKGROUND & AIMS We performed a phase 2 trial of the efficacy and safety of 4, 6, and 8 weeks of sofosbuvir, given in combination with the NS5A inhibitor velpatasvir and the NS3/4A protease inhibitor GS-9857, in patients with hepatitis C virus (HCV) infection. METHODS We enrolled 161 treatment-naïve or previously treated patients infected with HCV genotypes 1 or 3 with or without compensated...

2016
Ennio Polilli Valeria Cento Umberto Restelli Francesca Ceccherini-Silberstein Marianna Aragri Velia Chiara Di Maio Antonina Sciacca Fiorenzo Santoleri Paolo Fazii Alberto Costantini Carlo Federico Perno Giustino Parruti

Available commercial assays may yield inaccurate hepatitis C virus (HCV) genotype assignment in up to 10% of cases. We investigated the cost-effectiveness of re-evaluating HCV genotype by population sequencing, prior to choosing a direct acting antiviral (DAA) regimen. Between March and September 2015, HCV sequence analysis was performed in order to confirm commercial LiPA-HCV genotype (Versant...

Journal: :Gut 2007
C Hourioux R Patient A Morin E Blanchard A Moreau S Trassard B Giraudeau P Roingeard

BACKGROUND AND AIMS The prevalence and severity of liver steatosis are higher in patients infected with genotype 3 hepatitis C virus (HCV) than in patients infected with other genotypes. HCV core protein is known to affect lipid metabolism, inducing lipid droplet accumulation both in vitro and in vivo. An in vitro cellular model was used to investigate whether an HCV core protein with residues ...

Journal: :The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2005
Patrícia L Gonçalves Carla B Cunha Solange C U Busek Guilherme C Oliveira Rodrigo Ribeiro-Rodrigues Fausto E L Pereira

We examined the frequency of HCV-RNA in saliva samples from anti-HCV positive patients. Both plasma and saliva samples from 39 HCV patients (13 with normal liver enzymes, 19 with abnormal liver enzymes and 13 with cirrhosis) were investigated. Stimulated saliva and fresh plasma were centrifuged (900 x g,10 min) and stored at -70 degrees C, after the addition of guanidine isothiocyanate RNA extr...

Journal: :Enfermedades infecciosas y microbiologia clinica 2006
José Manuel Echevarría Pilar León Francisco Pozo Ana Avellón

BACKGROUND Recent data suggest that the prevalence of genotype 4 HCV strains among Spanish carriers is increasing. OBJECTIVE To assess changes in the prevalence of HCV genotypes in Spain during the last nine years. METHODS HCV RNA was amplified by the polymerase chain reaction from 3161 serum samples from unselected, anti-HCV-positive individuals, and the HCV genotype was identified by a re...

Journal: :The Journal of general virology 1994
L Z Xu D Larzul E Delaporte C Bréchot D Kremsdorf

Following a survey of hepatitis C virus (HCV) infection recently carried in central Africa (Gabon), we cloned and sequenced PCR products of the 5' non-coding and capsid-encoding regions of HCV RNA from three randomly selected HCV RNA-positive Gabonese subjects. In the capsid-encoding region, the identity between the three Gabonese isolates was 91 to 98%. The three Gabonese sequences showed a di...

Journal: :Journal of Korean Medical Science 2001
Y. S. Lee S. K. Yoon E. S. Chung S. H. Bae J. Y. Choi J. Y. Han K. W. Chung H. S. Sun B. S. Kim B. K. Kim

It is unclear whether serum ALT levels or virological characteristics of hepatitis C virus(HCV) including HCV genotypes and HCV RNA titers, can reflect the degree of histological injury in chronic hepatitis C. The aim of this study was to investigate the relationships between the levels of histological damage and serum ALT levels, HCV genotypes or circulating HCV RNA titers in chronic hepatitis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید